Descriptor
Acquired Immune Deficiency… | 2 |
Disease Control | 2 |
Drug Therapy | 2 |
Higher Education | 2 |
Laboratory Experiments | 2 |
Pharmacology | 2 |
Microbiology | 1 |
Source
American Journal of… | 2 |
Publication Type
Journal Articles | 2 |
Reports - Evaluative | 2 |
Education Level
Audience
Researchers | 2 |
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating

Prongay, Andrew J. – American Journal of Pharmaceutical Education, 1991
The importance of targeting certain stages in the life cycle of the virus for antiviral therapy is discussed with reference to the Human Immunodeficiency Virus type 1. Research conducted on a core antigen, p24, is described. (MSE)
Descriptors: Acquired Immune Deficiency Syndrome, Disease Control, Drug Therapy, Higher Education

Goldman, Mark E. – American Journal of Pharmaceutical Education, 1991
The molecular properties of Human Immunodeficiency Virus type 1 (HIV-1) reverse transcriptase are summarized and several strategies developed to inhibit its activity are described. (MSE)
Descriptors: Acquired Immune Deficiency Syndrome, Disease Control, Drug Therapy, Higher Education